Had a bad reaction to semaglutide? Here's how to tell what matters

The biggest misconception: every unpleasant symptom is a dangerous reaction

This is the myth worth correcting first. When people search for a bad reaction to Wegovy, they're often in the middle of nausea or an upset stomach and wondering whether to stop treatment immediately. The evidence doesn't support that as a default response. The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, burping, headache, dizziness, fatigue and injection-site reactions as common effects — common meaning they were reported by a meaningful proportion of trial participants, not that they're trivial, but also not that they indicate harm.

The pattern is consistent: symptoms tend to be most noticeable when treatment starts or after each dose increase, then reduce over days to a couple of weeks as the body adapts. Eating smaller meals, avoiding very fatty or spicy food, and staying well hydrated all make the adjustment period easier. That's practical, not dismissive. If the reaction to Wegovy feels unmanageable, the right move is to contact your prescriber, not to push through alone, and not to assume the worst.

What the misconception misses is that there's a meaningful difference between a reaction that's unpleasant and one that's clinically urgent. The sections below draw that line clearly.

Reactions that need prompt or urgent medical help

Some symptoms associated with semaglutide require medical attention the same day or faster, not a message to the pharmacy, but a call to 111 or, in serious cases, 999. In January 2026 the MHRA issued a Drug Safety Update specifically for GLP-1 medicines, highlighting acute pancreatitis as an infrequent but serious risk. The warning sign is severe, persistent stomach pain that doesn't ease and may radiate to the back, sometimes with vomiting. Do not wait that one out.

Other symptoms that should prompt urgent action include signs of a serious allergic reaction: swelling of the face, lips, tongue or throat, difficulty breathing, or a rash developing rapidly across the body. If you have any reason to suspect an allergic reaction to semaglutide, call emergency services. Gallbladder problems (sharp pain in the upper right abdomen, fever, yellowing of the skin) are another documented risk with GLP-1 medicines; again, prompt assessment rather than waiting.

Severe or prolonged vomiting and diarrhoea can lead to dehydration quickly enough to affect kidney function; if you cannot keep fluids down for more than a day, contact 111. People with a history of depression or mood changes should be aware that any new or worsening low mood, self-harm thoughts, or anxiety warrants a conversation with a doctor. These are rarer, but on the list for a reason.

What distinguishes an adverse reaction from the expected adjustment period

The clinical shorthand is duration and severity. An adverse reaction to Wegovy that is genuinely concerning tends to be: more intense than expected for GI effects, persistent rather than peaking and fading, or involves a body system well outside the gut, heart rate, skin, breathing, vision. The expected adjustment period involves gut symptoms that are noticeable but don't prevent you functioning, and that gradually ease rather than escalate.

Some patients describe night-time diarrhoea on Wegovy as particularly disruptive; this is a documented pattern and worth raising with your prescriber if it's affecting sleep, since there are practical steps that can reduce it. Skin effects are another question we hear regularly, local skin reactions at the injection site are common, usually mild and self-limiting, but widespread rash or hives are different and need assessment.

If you're ever unsure whether what you're experiencing falls into the normal-adjustment category or the call-your-prescriber category, the answer is: call your prescriber. Uncertainty itself is a reason to check in, not to wait. Our prescribers at nume discuss suitability and side effects as part of every consultation, before treatment starts, so the picture is clear from the outset.

Reporting a suspected reaction and keeping your prescriber in the loop

Any suspected side effect from semaglutide (whether or not you think it's serious) can be reported to the MHRA via the Yellow Card scheme. This applies to patients directly, not just to clinicians. The scheme's data feeds into post-market safety monitoring, which is how the January 2026 pancreatitis update came about: real-world reports contributing to regulatory action. You can also report suspect sellers of weight-loss medicines through the same route, which matters given the documented counterfeit pen problem in the UK.

Keep your prescriber informed of any reaction, even if it resolves. This is especially relevant for more pronounced side effects of semaglutide that affected your ability to take doses as scheduled, since missed or delayed injections can affect the titration plan. At nume, every repeat order goes through a clinical re-review, not a box-tick, but a genuine check that includes how the current dose has been tolerated. If a reaction has been difficult, that review is the right time to address it. You can also reach the team directly through our support line, available seven days a week. For a broader overview of how Wegovy works and what treatment involves, the Wegovy information page covers the full picture.